These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 33013699)

  • 1. Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study.
    Sun S; Jiao M; Han C; Zhang Q; Shi W; Shi J; Li X
    Front Endocrinol (Lausanne); 2020; 11():621. PubMed ID: 33013699
    [No Abstract]   [Full Text] [Related]  

  • 2. A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa.
    Chen S; Sun S; Cai M; Zhou Z; Ma Y; Zhou Z; Wang F; Liu J; Song W; Liu Y; Huang K; Yang Q; Guo Y
    J Ovarian Res; 2024 Aug; 17(1):166. PubMed ID: 39143642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.
    Xiao G; He Q; Liu L; Zhang T; Zhou M; Li X; Chen Y; Chen Y; Qin C
    J Transl Med; 2022 Oct; 20(1):475. PubMed ID: 36266699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic insights of blood lipid metabolites on polycystic ovary syndrome risk: a bidirectional two-sample Mendelian randomization study.
    Wang X; Han H; Shi X; Nie X; Zhu R; Jin J; Zhou H
    Front Endocrinol (Lausanne); 2024; 15():1391826. PubMed ID: 39045272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal relationships exist between polycystic ovary syndrome and adverse pregnancy and perinatal outcomes: a Mendelian randomization study.
    Ma Y; Cai J; Liu LW; Wen T; Huang W; Hou W; Wei Z; Xu Y; Xu Y; Wang Y; Mai Q
    Front Endocrinol (Lausanne); 2024; 15():1327849. PubMed ID: 39006363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome.
    Guo X; Chen L; He J; Zhang X; Xu S
    BMC Womens Health; 2024 Jun; 24(1):357. PubMed ID: 38902677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index and Polycystic Ovary Syndrome: A 2-Sample Bidirectional Mendelian Randomization Study.
    Zhao Y; Xu Y; Wang X; Xu L; Chen J; Gao C; Wu C; Pan D; Zhang Q; Zhou J; Chen R; Wang Z; Zhao H; You L; Cao Y; Li Z; Shi Y
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32163573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the causal impact of polycystic ovary syndrome on gestational diabetes mellitus: a two-sample Mendelian randomization study.
    Guixue G; Yifu P; Xiaofeng T; Qian S; Yuan G; Wen Y; Conghui H; Zuobin Z
    Front Endocrinol (Lausanne); 2024; 15():1337562. PubMed ID: 38375192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a Mendelian randomization study.
    Chen S; Zhou Z; Zhou Z; Liu Y; Sun S; Huang K; Yang Q; Guo Y
    Front Endocrinol (Lausanne); 2024; 15():1307944. PubMed ID: 38737546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis.
    Jiang X; Deng Q; Stener-Victorin E
    Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional Mendelian randomization to explore the causal relationships between body mass index and polycystic ovary syndrome.
    Brower MA; Hai Y; Jones MR; Guo X; Chen YI; Rotter JI; Krauss RM; Legro RS; Azziz R; Goodarzi MO
    Hum Reprod; 2019 Jan; 34(1):127-136. PubMed ID: 30496407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome and 25-hydroxyvitamin D: A bidirectional two-sample Mendelian randomization study.
    Zhang N; Liao Y; Zhao H; Chen T; Jia F; Yu Y; Zhu S; Wang C; Zhang W; Liu X
    Front Endocrinol (Lausanne); 2023; 14():1110341. PubMed ID: 36967791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic evidence for the causal association between type 1 diabetes and the risk of polycystic ovary syndrome.
    Chen S; Guo Z; Yu Q
    Hum Genomics; 2023 Nov; 17(1):100. PubMed ID: 37957681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis.
    Wen Y; Wu X; Peng H; Li C; Jiang Y; Su Z; Liang H; Liu J; He J; Liang W
    Breast Cancer Res Treat; 2021 Feb; 185(3):799-806. PubMed ID: 33128677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically Predicted Cigarette Smoking in Relation to Risk of Polycystic Ovary Syndrome.
    Tao Y; Liu B; Chen Y; Hu Y; Zhu R; Ye D; Mao Y; Sun X
    Clin Epidemiol; 2021; 13():527-532. PubMed ID: 34239329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal effects of genetically determined metabolites and metabolite ratios on esophageal diseases: a two-sample Mendelian randomization study.
    Yang H; Wang Y; Zhao Y; Cao L; Chen C; Yu W
    BMC Gastroenterol; 2024 Sep; 24(1):310. PubMed ID: 39271994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota and polycystic ovary syndrome, focus on genetic associations: a bidirectional Mendelian randomization study.
    Wang J; Fiori PL; Capobianco G; Carru C; Chen Z
    Front Endocrinol (Lausanne); 2024; 15():1275419. PubMed ID: 38318294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal relationships between genetically determined metabolites and human intelligence: a Mendelian randomization study.
    Yang J; Zhao B; Qian L; Gao F; Fan Y; He X; Ma Q; Yang L; Yan B; Wang W; Ma X
    Mol Brain; 2021 Feb; 14(1):29. PubMed ID: 33563321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age at menarche and polycystic ovary syndrome: A Mendelian randomization study.
    Ma Y; Cai J; Liu LW; Hou W; Wei Z; Wang Y; Xu Y
    Int J Gynaecol Obstet; 2023 Sep; 162(3):1050-1056. PubMed ID: 37128830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal relationships between modifiable risk factors and polycystic ovary syndrome: a comprehensive Mendelian randomization study.
    Zhao Y; Pang J; Fang X; Yan Z; Yang H; Deng Q; Ma T; Lv M; Li Y; Tu Z; Zou L
    Front Endocrinol (Lausanne); 2024; 15():1348368. PubMed ID: 38779450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.